Início › Câncer (todos os tipos) › Texas › San Antonio
Ensaios clínicos de Câncer (todos os tipos) em San Antonio, TX
41 estudos para Câncer (todos os tipos) estão buscando participantes em locais em San Antonio e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of ASP3082 in Adults With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
RecrutandoFase 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RecrutandoFase 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
RecrutandoFase 1
- NEXT Oncology ( Site 0151), San Antonio
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
RecrutandoFase 2
- Mays Cancer Center ( Site 0039), San Antonio
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
RecrutandoFase 1
- GSK Investigational Site, San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RecrutandoFase 1
- NEXT Oncology, San Antonio
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
RecrutandoFase 3
- START San Antonio ( Site 0104), San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RecrutandoFase 2/3
- Sam Clinical Research Center, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
RecrutandoFase 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology, San Antonio
Prostate Active Surveillance Study
RecrutandoEstudo observacional
- University of Texas Health Science Center, San Antonio, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecrutandoFase 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RecrutandoFase 1
- NEXT Oncology, San Antonio
Project: Every Child for Younger Patients With Cancer
RecrutandoEstudo observacional
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
RecrutandoFase 1/2
- Site 01, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
RecrutandoFase 1
- NEXT Oncology San Antonio, San Antonio
- START- San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RecrutandoFase 1
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
RecrutandoFase 1
- START San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
RecrutandoFase 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
RecrutandoFase 3
- Texas Oncology San Antonio Medical Center, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecrutandoFase 1
- START San Antonio, LLC., San Antonio
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RecrutandoFase 1
- USA Clinical Trials, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- START, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
RecrutandoFase 1
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecrutandoFase 1
- Research Site #2, San Antonio
- Research Site, San Antonio
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
RecrutandoFase 1
- GSK Investigational Site, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
RecrutandoFase 1/2
- NEXT Oncology, San Antonio
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- NEXT San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RecrutandoFase 1
- NEXT Oncology San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
RecrutandoFase 1
- UT Health, San Antonio
A Study of YL242 in Subjects With Advanced Solid Tumors
RecrutandoFase 1/2
- US-207, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
RecrutandoFase 1
- NEXT Oncology, San Antonio
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
RecrutandoFase 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RecrutandoFase 1/2
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recrutando
- University of Texas Health Science Center at San Antonio, San Antonio
Ensaios de Câncer (todos os tipos) em outras cidades
- Houston, TX121 estudos
- New York City, NY110 estudos
- Boston, MA86 estudos
- Los Angeles, CA73 estudos
- Nashville, TN65 estudos
- Philadelphia, PA59 estudos
- Durham, NC58 estudos
- Washington, DC58 estudos
- Chicago, IL51 estudos
- Seattle, WA49 estudos
- Atlanta, GA49 estudos
- Arlington, VA48 estudos
Outros estudos em San Antonio
- Câncer de Pulmão de Não Pequenas Células59 estudos
- Câncer Colorretal46 estudos
- Câncer de Mama46 estudos
- Câncer Metastático44 estudos
- Obesidade40 estudos
- Diabetes tipo 237 estudos
- Sobrepeso34 estudos
- Câncer de Ovário31 estudos
- Câncer de Pâncreas31 estudos
- Câncer de Próstata28 estudos
- Câncer Endometrial27 estudos
- Câncer de Pulmão26 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.